Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is giving a ...

Johnson & Johnson has dropped a pair of CAR-T cell therapies, axing programs it once predicted could deliver peak sales north ...

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

In this retrospective analysis, researchers used real-world data to investigate sex-associated differences in CAR T-cell therapy-related toxicity.

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models ...

Satri-cel CAR-T therapy could become the world’s first approved CAR-T treatment for solid tumors, offering new hope for ...

By Nancy Lapid May 1 (Reuters) - We also report on a new use for artificial intelligence that could help eliminate some ...

Researchers have developed a sensitive CAR-T therapy that targets 'faint' proteins in solid tumors, potentially transforming cancer treatment.

CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR ...

Add Yahoo as a preferred source to see more of our stories on Google. For over a decade, CAR-T cell therapy has revolutionized cancer treatment, offering a powerful tool to harness the body’s immune ...

Rutgers University researchers find that certain aging immune T cells can blunt cell expansion and may help explain why many ...